Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNYNF) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to -$1.2 billion.

  • Sanofi's Tax Provisions rose 562.58% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.6 billion, marking a year-over-year decrease of 4739.77%. This contributed to the annual value of -$1.2 billion for FY2025, which is 954.92% up from last year.
  • Per Sanofi's latest filing, its Tax Provisions stood at -$1.2 billion for Q4 2025, which was up 562.58% from -$1.6 billion recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Tax Provisions peaked at -$113.0 million during Q1 2024, and registered a low of -$1.6 billion during Q3 2025.
  • In the last 5 years, Sanofi's Tax Provisions had a median value of -$499.3 million in 2023 and averaged -$623.4 million.
  • Per our database at Business Quant, Sanofi's Tax Provisions surged by 7706.72% in 2024 and then crashed by 34782.18% in 2025.
  • Sanofi's Tax Provisions (Quarter) stood at -$306.6 million in 2021, then tumbled by 202.83% to -$928.4 million in 2022, then dropped by 17.86% to -$1.1 billion in 2023, then dropped by 17.58% to -$1.3 billion in 2024, then increased by 5.63% to -$1.2 billion in 2025.
  • Its last three reported values are -$1.2 billion in Q4 2025, -$1.6 billion for Q3 2025, and -$260.4 million during Q2 2025.